title: Telmisartan vs. enalapril in type 2 diabetes.
authors.forename: Ali Ali
authors.initials: AA
authors.lastname: Asgari
authors.forename: Farzaneh
authors.initials: F
authors.lastname: Sarvghadi
authors.forename: Nargessadat
authors.initials: N
authors.lastname: Zahed
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004656:Enalapril / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias; D012307:Risk Factors; D000077333:Telmisartan
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D001786:Blood Glucose; D004656:Enalapril; D000077333:Telmisartan